%0 Journal Article
%T 骨肉瘤的诊断及生物学治疗进展<br> Diagnosis and Progress in Biological Treatment of Osteosarcoma
%A 谢欣蓉
%A 林天昌
%A 刘志萍
%A 唐昊宇
%A 钟清凯
%A 程丽佳
%J Hans Journal of Biomedicine
%P 114-120
%@ 2161-8984
%D 2019
%I Hans Publishing
%R 10.12677/HJBM.2019.93017
%X <div style=\"text-align:justify;\">
	<span style=\"font-size:14px;\">骨肉瘤是严重威胁患者健康和生命的一种原发性恶性肿瘤。随着医疗科学技术的发展，治疗方法日益多样，近几年多提倡手术治疗与化疗结合的综合性治疗方案，这能将患者五年生存率提高至60%~70%。为了提高患者生存质量，延长患者生存时间，骨肉瘤治疗的关键在于对骨肉瘤的早发现，早治疗。本文就目前骨肉瘤的诊断方式和近年来骨肉瘤在免疫信号通路、血管靶向、修饰T细胞、等方面取得的研究进展进行综述。<br />
Osteosarcoma is a primary malignant tumor
that seriously threatens the health and life of patients. With the development
of medical science and technology, treatment methods are becoming more and more
diverse. In recent years, more comprehensive treatment schemes combining
surgical treatment and chemotherapy are advocated, which can improve the
five-year survival rate of patients to 60% - 70%. In order to improve the
quality of life and prolong the survival time of patients, the key to the
treatment of osteosarcoma lies in the early detection and treatment of osteosarcoma.
This article reviews the current diagnostic methods of osteosarcoma and recent
advances in immune signaling pathways, vascular targeting, modified T cells and
other aspects of osteosarcoma.</span> 
</div>
%K 骨肉瘤，诊断，免疫治疗，PD-1，CAR-T<br> Osteosarcoma
%K Diagnosis
%K Immunotherapy
%K PD-1
%K CAR-T
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=31133